- Home
- SGP vs ROOT Comparison
SGP vs ROOT Comparison
Compare SGP & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SGP | ROOT |
|---|---|---|
| Founded | 2019 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 932.9M | 804.6M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | SGP | ROOT |
|---|---|---|
| Price | $25.12 | $54.71 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $45.00 | ★ $92.40 |
| AVG Volume (30 Days) | 86.6K | ★ 278.0K |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.96 |
| EPS | N/A | ★ 2.36 |
| Revenue | N/A | ★ $1,517,100,000.00 |
| Revenue This Year | N/A | $11.73 |
| Revenue Next Year | N/A | $12.80 |
| P/E Ratio | ★ N/A | $21.92 |
| Revenue Growth | N/A | ★ 28.95 |
| 52 Week Low | $20.15 | $40.91 |
| 52 Week High | $30.56 | $162.99 |
Technical Indicators
Market Signals| Indicator | SGP | ROOT |
|---|---|---|
| Relative Strength Index (RSI) | 52.02 | 64.96 |
| Support Level | $20.60 | $41.78 |
| Resistance Level | $28.17 | $63.33 |
| Average True Range (ATR) | 1.91 | 2.36 |
| MACD | 0.36 | 1.45 |
| Stochastic Oscillator | 66.01 | 88.96 |
Price Performance
Historical ComparisonAbout SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.